Medline Introduces Wheelchair With Microban Antimicrobial Protection

Article

Medline Industries, Inc. recently launched the first wheelchair exclusively featuring built-in Microban® antimicrobial protection that provides an added level of protection against damaging microbes such as bacteria, mold and mildew that can cause stains, odors and product deterioration. The chair is currently patent pending.

All major contact surfaces on Medline's new Excel XW (extra wide) wheelchair are infused with Microban® antimicrobial protection, including all upholstery, surfaces, pushrims, tires, painted frame, and other contact surfaces, keeping these surfaces cleaner between cleanings.

"By incorporating Microban® antimicrobial technology, we are making a promise to our customers that our wheelchairs provide continuous, durable and effective antimicrobial protection," says Rich Derks, president of Medline's Durable Medical Equipment Division. "What this means is that our customers can rely on our wheelchairs being high quality and long lasting."

The Medline wheelchairs with Microban protection also feature arm pads that adjust between desk length and full length position with the push of a button. The wheelchair has a seat size of 22 inches wide by 18 inches deep, a weight capacity of 500 pounds and a detachable, elevating footrest.

The new Excel XW will be on display at Medtrade in Atlanta, Oct. 24-27, 2011 at booth 1638.

Recent Videos
Annet Adegboyega, DNP, MSN, BSN, RN, CNOR; Mihyun "Rose" Jang, MSN, MPH, BSN, RN, CNOR; and Renilda Tijones, MSN, BSN, RN, CNOR.
Roundtable of Vet IPs (Adobe Stock)
APIC 2025 President Carol McLay, DrPH, MPH, RN, CIC FAPIC   (Image credit: APIC)
Paulo J. M. Brois, DVM, MSN, RN; Luisa M. P. Soares, RN; and Teresa A. Santos, RN, at #AORN2025
Michael Sinnott, MBBS, FACEM, FRACP, at 2025 AORN Global Conference & Expo.
Roundtable of Vet IPs
Meet Marjorie Wall, EDBA, CRCST, CIS, CHL, CSSBB.
A veterinarian in a protective suit takes tests on animals on a farm.   (Adobe Stock 829620654 by Яна Ерік Татевосян)
David Angulo, MD, President and Chief Executive Officer, Fungal Disease Expert
Related Content